We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZEOWW
10176
Zeo Energy Corp Warrants
ZEOWW
$141K
$0 ﹤0.01%
1
-3
-75%
AMDL icon
10177
GraniteShares 2x Long AMD Daily ETF
AMDL
$762M
-817
Closed -$18.1K
DJTWW
10178
Trump Media & Technology Group Warrants
DJTWW
$790M
-451
Closed -$12.4K
GCTS.WS
10179
GCT Semiconductor Holding Warrants
GCTS.WS
$14.4M
-981
Closed -$373
PDYNW icon
10180
Palladyne AI Corp Warrants
PDYNW
$240K
-152
Closed -$8
LSBPW
10181
DELISTED
LakeShore Biopharma Warrants
LSBPW
-68
Closed -$5
INCE
10182
Franklin Income Equity Focus ETF
INCE
$132M
-3
Closed -$164
INEQ
10183
Columbia International Equity Income ETF
INEQ
$97.1M
-50
Closed -$1.53K
ATYR
10184
aTyr Pharma
ATYR
$47.4M
-20,192
Closed -$39.4K
FSCS
10185
First Trust SMID Capital Strength ETF
FSCS
$58.6M
-63
Closed -$2.09K
QHY
10186
WisdomTree U.S. High Yield Corporate Bond Fund
QHY
$236M
-2,010
Closed -$91.1K
QIG
10187
WisdomTree U.S. Corporate Bond Fund
QIG
$17.4M
-19
Closed -$842
RIME
10188
Algorhythm Holdings
RIME
$6.2M
-3
Closed -$512
SAIH
10189
SAIHEAT Ltd
SAIH
$34.8M
-44
Closed -$762
EONR.WS
10190
EON Resources Warrants
EONR.WS
-50
Closed -$7
SCNX
10191
Scienture Holdings
SCNX
$14.9M
-246
Closed -$2.52K
NIXX
10192
Nixxy Inc
NIXX
$18.6M
-35
Closed -$57
NIXXW
10193
DELISTED
Nixxy Inc Warrant
NIXXW
-5
Closed
EXE
10194
PUT
Expand Energy Corp
EXE
$22.1B
-377,500
Closed -$33.5M
IVF
10195
INVO Fertility Inc
IVF
$1.63M
-6
Closed -$9.15K
AIFU
10196
AIFU Inc
AIFU
$193M
-4
Closed -$8.47K
NBET
10197
Neuberger Energy Transition & Infrastructure ETF
NBET
$46.7M
-25
Closed -$668
UOKA
10198
DELISTED
MDJM Ltd
UOKA
0
-$6
FSGS
10199
First Trust SMID Growth Strength ETF
FSGS
$30.8M
-79
Closed -$2.28K
MSPR
10200
DELISTED
MSP Recovery Inc
MSPR
-1
Closed -$115

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.